0001225208-17-016030.txt : 20171005
0001225208-17-016030.hdr.sgml : 20171005
20171005161607
ACCESSION NUMBER: 0001225208-17-016030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171003
FILED AS OF DATE: 20171005
DATE AS OF CHANGE: 20171005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bose Supratim
CENTRAL INDEX KEY: 0001538431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 171124733
MAIL ADDRESS:
STREET 1: 11A COOLING CLOSE
CITY: SINGAPORE
STATE: U0
ZIP: 558176
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2017-10-03
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001538431
Bose Supratim
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & President, Asia-Pacific
Common Stock
2017-10-03
4
M
0
174672.0000
5.3600
A
494973.0000
D
Common Stock
2017-10-03
4
M
0
22145.0000
6.2800
A
517118.0000
D
Common Stock
2017-10-03
4
S
0
196817.0000
29.0789
D
320301.0000
D
Common Stock
2017-10-04
4
M
0
88071.0000
7.3900
A
408372.0000
D
Common Stock
2017-10-04
4
M
0
23907.0000
13.0800
A
432279.0000
D
Common Stock
2017-10-04
4
M
0
15352.0000
6.2800
A
447631.0000
D
Common Stock
2017-10-04
4
M
0
15086.0000
16.3100
A
462717.0000
D
Common Stock
2017-10-04
4
M
0
7904.0000
17.2600
A
470621.0000
D
Common Stock
2017-10-04
4
S
0
150320.0000
29.1800
D
320301.0000
D
Stock Option (Right to Buy)
5.3600
2017-10-03
4
M
0
174672.0000
0.0000
D
2022-01-03
Common Stock
174672.0000
0.0000
D
Stock Option (Right to Buy)
6.2800
2017-10-03
4
M
0
22145.0000
0.0000
D
2022-02-27
Common Stock
22145.0000
15352.0000
D
Stock Option (Right to Buy)
17.2600
2017-10-04
4
M
0
7904.0000
0.0000
D
2026-02-22
Common Stock
7904.0000
23714.0000
D
Stock Option (Right to Buy)
16.3100
2017-10-04
4
M
0
15086.0000
0.0000
D
2025-02-23
Common Stock
15086.0000
15086.0000
D
Stock Option (Right to Buy)
13.0800
2017-10-04
4
M
0
23907.0000
0.0000
D
2024-02-24
Common Stock
23907.0000
7969.0000
D
Stock Option (Right to Buy)
6.2800
2017-10-04
4
M
0
15352.0000
0.0000
D
2022-02-27
Common Stock
15352.0000
0.0000
D
Stock Option (Right to Buy)
7.3900
2017-10-04
4
M
0
88071.0000
0.0000
D
2023-02-28
Common Stock
88071.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.4901, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.255, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on January 3, 2013, the first anniversary of the grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
/s/ Vance R. Brown, Attorney-in-fact
2017-10-05